These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16308999)

  • 1. High dose statin therapy for all patients with coronary artery disease?
    Knobler H
    Isr Med Assoc J; 2005 Nov; 7(11):736-8. PubMed ID: 16308999
    [No Abstract]   [Full Text] [Related]  

  • 2. The intensive statin therapy myth.
    Shechter M; Beigel R; Matetzky S; Freimark D; Chouraqui P
    Isr Med Assoc J; 2005 Nov; 7(11):683-7. PubMed ID: 16308988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
    Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive statin therapy in coronary artery disease: is lower cholesterol better and safe?
    Seshasai SR; Ray KK
    Future Cardiol; 2009 Mar; 5(2):129-39. PubMed ID: 19371188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The power of statins: aggressive lipid lowering.
    Jones PH
    Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aggressive statin therapy reduces the progression of atherosclerosis-- DMW15/2005].
    Taut V
    Dtsch Med Wochenschr; 2006 Mar; 131(9):460; author reply 460. PubMed ID: 16493575
    [No Abstract]   [Full Text] [Related]  

  • 7. Changing face of dyslipidemia therapy.
    Banerjee AK
    Indian Heart J; 2008; 60(3):192-4. PubMed ID: 19240305
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
    Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy.
    Wiviott SD; Cannon CP
    Curr Opin Lipidol; 2006 Dec; 17(6):626-30. PubMed ID: 17095906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
    Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statins in coronary patients: a solved issue?].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 2008 Feb; 57 Suppl 1():16-23. PubMed ID: 18472029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein cholesterol-independent effects of statins on coronary artery disease.
    Takagi H; Umemoto T
    Am J Cardiol; 2011 Jan; 107(2):336. PubMed ID: 21211613
    [No Abstract]   [Full Text] [Related]  

  • 13. Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy.
    Rosenson RS
    Am Heart J; 2006 Mar; 151(3):556-63. PubMed ID: 16504615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
    Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS; Bissonnette S; Habib R; Boukas S;
    Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New studies of high dosage statins and fibrates. How is lipid lowering therapy changing? (interview by Dr. med. Dirk Einecke)].
    Klose G
    MMW Fortschr Med; 2005 Dec; 147(49-50):20. PubMed ID: 16401005
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy.
    Tamargo J; Caballero R; Gómez R; Núñez L; Vaquero M; Delpón E
    Pharmacol Ther; 2007 Apr; 114(1):107-26. PubMed ID: 17287023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying coronary plaque regression with IVUS.
    Nicholls SJ; Sipahi I
    J Interv Cardiol; 2006 Aug; 19(4):345. PubMed ID: 16881983
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 20. Pleiotropic effects of statins on cardiovascular events in the Japanese Coronary Artery Disease study.
    Fujita M; Yamazaki T; Hayashi D; Kohro T; Okada Y; Nagai R;
    Int J Cardiol; 2008 Sep; 129(2):294-6. PubMed ID: 17655954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.